Syndrome Charlese Bonneta jako první příznak Alzheimerovy choroby

Jakub Hort; L. Propper; D. Hořínek; D. Škoda; M. Bojar

Syndrome Charlese Bonneta jako první příznak Alzheimerovy choroby

Translated title of the contribution: Charles Bonnet syndrome as the first sign of Alzheimer's disease

Jakub Hort, L. Propper, D. Hořínek, D. Škoda, M. Bojar

Research output: Contribution to journal › Article › peer-review

Abstract

The authors have presented a case-report of a 75-year-old woman receiving psychopharmacological treatment due to five-years' history of visual pseudohallucinations. Four years after the onset, the patient was examined, and then followed by neurologists due to deterioration of her cognitive functions. She was extensively examined - neuropsychology, MRI volumometry, CSF assessment (including biomarkers total-tau protein, phosphorylated-tau protein, beta-amyloid), SPECT, DaTSCAN and laboratory screening. In accordance with clinical picture the results led to the diagnosis of Alzheimer's disease, which was initially manifested by Charles Bonnet syndrome. Differential diagnosis of dementias, particularly those with Lewy bodies, and a possible association of cognitive deficit with mental health issues (hallucinations) are discussed.

Translated title of the contribution	Charles Bonnet syndrome as the first sign of Alzheimer's disease
Original language	Czech
Pages (from-to)	141-143
Number of pages	3
Journal	Ceska a Slovenska Neurologie a Neurochirurgie
Volume	69
Issue number	2
Publication status	Published - 2006
Externally published	Yes

ASJC Scopus Subject Areas

Surgery
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{703d9064a854488d826aa1f88bdad301,

title = "Syndrome Charlese Bonneta jako prvn{\'i} p{\v r}{\'i}znak Alzheimerovy choroby",

abstract = "The authors have presented a case-report of a 75-year-old woman receiving psychopharmacological treatment due to five-years' history of visual pseudohallucinations. Four years after the onset, the patient was examined, and then followed by neurologists due to deterioration of her cognitive functions. She was extensively examined - neuropsychology, MRI volumometry, CSF assessment (including biomarkers total-tau protein, phosphorylated-tau protein, beta-amyloid), SPECT, DaTSCAN and laboratory screening. In accordance with clinical picture the results led to the diagnosis of Alzheimer's disease, which was initially manifested by Charles Bonnet syndrome. Differential diagnosis of dementias, particularly those with Lewy bodies, and a possible association of cognitive deficit with mental health issues (hallucinations) are discussed.",

author = "Jakub Hort and L. Propper and D. Ho{\v r}{\'i}nek and D. {\v S}koda and M. Bojar",

year = "2006",

language = "Tch{\`e}que",

volume = "69",

pages = "141--143",

journal = "Ceska a Slovenska Neurologie a Neurochirurgie",

issn = "1210-7859",

publisher = "Czech Medical Association J.E. Purkyne",

number = "2",

}

TY - JOUR

T1 - Syndrome Charlese Bonneta jako první příznak Alzheimerovy choroby

AU - Hort, Jakub

AU - Propper, L.

AU - Hořínek, D.

AU - Škoda, D.

AU - Bojar, M.

PY - 2006

Y1 - 2006

N2 - The authors have presented a case-report of a 75-year-old woman receiving psychopharmacological treatment due to five-years' history of visual pseudohallucinations. Four years after the onset, the patient was examined, and then followed by neurologists due to deterioration of her cognitive functions. She was extensively examined - neuropsychology, MRI volumometry, CSF assessment (including biomarkers total-tau protein, phosphorylated-tau protein, beta-amyloid), SPECT, DaTSCAN and laboratory screening. In accordance with clinical picture the results led to the diagnosis of Alzheimer's disease, which was initially manifested by Charles Bonnet syndrome. Differential diagnosis of dementias, particularly those with Lewy bodies, and a possible association of cognitive deficit with mental health issues (hallucinations) are discussed.

AB - The authors have presented a case-report of a 75-year-old woman receiving psychopharmacological treatment due to five-years' history of visual pseudohallucinations. Four years after the onset, the patient was examined, and then followed by neurologists due to deterioration of her cognitive functions. She was extensively examined - neuropsychology, MRI volumometry, CSF assessment (including biomarkers total-tau protein, phosphorylated-tau protein, beta-amyloid), SPECT, DaTSCAN and laboratory screening. In accordance with clinical picture the results led to the diagnosis of Alzheimer's disease, which was initially manifested by Charles Bonnet syndrome. Differential diagnosis of dementias, particularly those with Lewy bodies, and a possible association of cognitive deficit with mental health issues (hallucinations) are discussed.

UR - http://www.scopus.com/inward/record.url?scp=33645648875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645648875&partnerID=8YFLogxK

M3 - Artículo

AN - SCOPUS:33645648875

SN - 1210-7859

VL - 69

SP - 141

EP - 143

JO - Ceska a Slovenska Neurologie a Neurochirurgie

JF - Ceska a Slovenska Neurologie a Neurochirurgie

IS - 2

ER -

Syndrome Charlese Bonneta jako první příznak Alzheimerovy choroby

Abstract

ASJC Scopus Subject Areas

UN SDGs

Other files and links

Fingerprint

Cite this